Skip to main content

and
  1. No Access

    Chapter

    Immune Complex Therapies for Treatment of Immune Thrombocytopenia

    Approximately 30% of patients with chronic immune thrombocytopenia (ITP), a common autoimmune disease, are refractory to standard therapies. In the last several years, several published reports have suggested ...

    Rong Deng, Joseph P. Balthasar in Development of Antibody-Based Therapeutics (2012)

  2. No Access

    Chapter

    Monoclonal Antibodies

    Since the approval of rituximab in 1997 for the treatment of non-Hodgkin’s lymphoma, over 11 monoclonal antibodies (mAbs) have been approved for the treatment of cancer and hundreds are under development. Char...

    Shuang Bai Ph.D., Rong Deng Ph.D. in Handbook of Anticancer Pharmacokinetics an… (2014)